Global Needle Free Diabetes Management Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022

Global Needle Free Diabetes Management Market is Expected to Reach USD 9,797.8 Mn by 2022

The latest market report published by Credence Research, Inc. “Global Needle Free Diabetes Management Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 - 2022,” the needle free diabetes management market was valued at USD 3,225.6 Mn in 2015, and is expected to reach USD 9,797.8 Mn by 2022, expanding at a CAGR of 16.8% from 2016 to 2022.

Browse the full report Needle Free Diabetes Management Market - Growth, Share, Opportunities, Competitive Analysis, and Forecast, 2016 – 2022 report at http://www.credenceresearch.com/report/needle-free-diabetes-management-market

Market Insights:

Diabetes is majorly classified into Type 1 diabetes (due to b-cell destruction, usually leading to absolute insulin deficiency), Type 2 diabetes (due to a progressive loss of insulin secretion on the background of insulin resistance) and gestational diabetes mellitus (GDM) (diabetes diagnosed in the second or third trimester of pregnancy that is not clearly overt diabetes).

According to the International Diabetes Federation, in 2015 about 415 million people were observed suffering with diabetes and by 2040 the number is expected to soar to 642 million worldwide. In 2015, North America and Caribbean comprised patient population of 44.3 million, Europe possessed 59.8 million, South East Asia had 78.3 million, Western Pacific had 153.2 million, South & Central America had 29.6 million, and Africa had 14.2 million.

Request for sample @ http://www.credenceresearch.com/sample-request/58012

The market segmentation of needle free diabetes management market is carried out on the basis of type of devices and geography. The devices segment is further sub-segmented into treatment devices, diagnostic devices and artificial pancreas. Treatment devices comprise of insulin pens, pumps & patches, inhalers and jet injectors.

Insulin patch & pump was observed as the...